ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: CD26+ CML LSCs derived from chronic-phase CML patients were capable of inducing BCR-ABL+ engraftment in NOD-SCID-IL-2Rγ−/− (NSG) mice [35].